# VaxAtlas

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vaxatlas

- Industry: Healthcare
- Headquarters: Boston, US
- Website: www.vaxatlas.com
- Latest round: Seed (Apr 13, 2021)
- Investors on record: 1

## About

Based in Boston, MA, VaxAtlas, Inc. offers a digital platform focused on comprehensive vaccination data management, providing healthcare providers, researchers, and public health officials with vital resources to track and analyze immunization trends and vaccination rates.VaxAtlas, Inc. is a company that specializes in vaccination data management solutions. Founded in 2015 and headquartered in Boston, US, the company has made a significant impact in the public health sector. In April 2021, VaxAtlas raised an undisclosed amount of SEED funding to enhance their offerings, particularly addressing the challenges posed by COVID-19 vaccination management. The founder's background includes prior experience in health technology, supporting their vision for VaxAtlas. As of now, the company has completed one deal.VaxAtlas, Inc. specializes in providing a digital platform that serves as a comprehensive resource for vaccination data management. The core offering includes an interactive database that enables healthcare providers, researchers, and public health officials to access real-time vaccination information, track vaccination rates, and analyze immunization trends. This service addresses the growing need for accurate vaccination records and insights, particularly in response to public health challenges such as outbreaks and vaccination hesitancy. The platform caters to a wide client base, including government health departments, healthcare institutions, and pharmaceutical companies, primarily within North America and Europe, where vaccination tracking is critical for effective health policy. By providing robust data analytics and visualization tools, VaxAtlas supports end-users in making informed decisions that enhance public health outcomes.VaxAtlas, Inc. generates revenue through a subscription-based model, where clients pay an annual fee to access the platform's comprehensive data services. Various pricing tiers exist to cater to the needs of different user groups, including government agencies and private organizations. Transactions typically involve direct contractual agreements that outline service terms, including data access levels and support services provided. For example, a government health department may enter into a partnership with VaxAtlas to obtain detailed vaccination analytics that inform their public health initiatives. The flagship services include advanced data analysis tools and customizable reporting features, integral to the platform's value proposition, ensuring that clients receive tailored insights relevant to their specific vaccination programs.Following the SEED funding raised in April 2021, VaxAtlas, Inc. aims to further develop its platform by introducing new features that will assist individuals and employers in navigating COVID-19 vaccine information. The company plans to expand its services into emerging markets in Latin America and Southeast Asia by 2023, focusing on regions where vaccination data management is increasingly critical. The funding will be utilized to enhance product development and marketing efforts to support this strategic expansion, ensuring the platform meets the diverse needs of clients across various geographies.

## Funding rounds

- Seed, Apr 13, 2021 — NFP Ventures

## Investors

- NFP Ventures (https://capitalatlas.ai/funds/nfp-ventures) — Seed